US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist
  • 26.190
  • -0.050-0.19%
Close Nov 12 16:00 ET
  • 26.250
  • +0.060+0.23%
Post 20:01 ET
148.42BMarket Cap34.92P/E (TTM)

Pfizer Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 29, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Oct 1, 2023
(Q2)Jul 2, 2023
(Q1)Apr 2, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
94.13%6.71B
-47.31%-1.78B
-9.91%1.09B
-70.27%8.7B
-38.93%5.24B
-42.07%3.46B
-114.79%-1.21B
-81.49%1.21B
-11.10%29.27B
44.70%8.58B
Net income from continuing operations
287.65%4.48B
-98.68%31M
-43.69%3.13B
-93.08%2.17B
-166.69%-3.34B
-127.63%-2.39B
-76.31%2.34B
-29.50%5.56B
39.81%31.4B
39.77%5B
Depreciation and amortization
12.50%1.76B
10.04%1.73B
16.75%1.74B
24.21%6.29B
9.94%1.67B
31.87%1.56B
33.87%1.57B
25.27%1.49B
-2.45%5.06B
13.78%1.52B
Deferred tax
-326.55%-482M
10.31%-783M
26.25%-441M
8.55%-3.44B
-409.04%-1.86B
-282.26%-113M
23.42%-873M
74.24%-598M
12.32%-3.76B
46.56%-365M
Other non cash items
-46.69%-842M
151.02%274M
-253.00%-353M
-970.00%-4.28B
-127.50%-3.07B
-228.00%-574M
-175.10%-537M
-124.45%-100M
91.48%-400M
-47.27%-1.35B
Change In working capital
173.31%879M
9.73%-3.54B
39.42%-3.34B
61.48%-2.17B
246.03%8.45B
73.85%-1.2B
-41.58%-3.92B
-654.38%-5.51B
-144.04%-5.64B
26.07%2.44B
-Change in receivables
----
----
----
32.95%347M
----
----
----
----
106.85%261M
----
-Change in inventory
----
----
----
-97.80%-1.17B
----
----
----
----
47.47%-591M
----
-Change in payables and accrued expense
----
----
----
-125.19%-300M
----
----
----
----
-4.11%1.19B
----
-Change in other current assets
----
----
----
85.29%-663M
----
----
----
----
-326.30%-4.51B
----
-Change in other current liabilities
----
----
----
141.06%595M
----
----
----
----
-107.74%-1.45B
----
-Change in other working capital
----
----
----
-80.18%-982M
----
----
----
----
53.26%-545M
----
Cash from discontinued investing activities
0
0
Operating cash flow
94.27%6.71B
-47.43%-1.78B
-10.07%1.09B
-70.27%8.7B
-38.94%5.24B
-42.15%3.46B
-114.79%-1.21B
-81.47%1.21B
-10.17%29.27B
45.11%8.58B
Investing cash flow
Cash flow from continuing investing activities
-331.24%-2.06B
118.05%4.6B
-47.80%1.73B
-104.50%-32.28B
-149.31%-11B
242.40%890M
-125.26%-25.49B
484.83%3.32B
29.96%-15.78B
-70.84%-4.41B
Net PPE purchase and sale
19.63%-651M
30.31%-637M
38.19%-704M
-20.74%-3.91B
-4.30%-1.04B
3.69%-810M
-21.70%-914M
-77.14%-1.14B
-19.37%-3.24B
0.10%-1B
Net business purchase and sale
--0
--0
--3.49B
-88.85%-43.43B
-158.79%-43.41B
--0
---25M
--0
---23B
---16.77B
Net investment purchase and sale
-204.59%-1.41B
121.88%5.26B
-123.61%-1.06B
128.06%15.24B
150.40%33.44B
137.14%1.35B
-129.11%-24.02B
-39.94%4.47B
134.24%6.68B
911.79%13.35B
Net other investing changes
-98.28%6M
96.37%-19M
105.26%1M
6.25%-180M
66.67%15M
413.51%348M
-580.52%-524M
-46.15%-19M
37.25%-192M
-86.15%9M
Cash from discontinued investing activities
Investing cash flow
-331.64%-2.06B
118.05%4.6B
-47.75%1.73B
-104.51%-32.28B
-149.34%-11B
241.63%888M
-125.27%-25.49B
484.66%3.32B
30.00%-15.78B
-70.53%-4.41B
Financing cash flow
Cash flow from continuing financing activities
-22.68%-4.64B
-109.05%-2.46B
-77.95%-4.93B
275.72%26.07B
208.51%5.44B
34.40%-3.78B
977.95%27.18B
57.88%-2.77B
-51.12%-14.83B
-49.66%-5.02B
Net issuance payments of debt
-57.56%-2.25B
-100.05%-16M
-6,690.63%-2.17B
1,122.33%35.95B
379.98%7.78B
59.44%-1.43B
542.59%29.63B
98.25%-32M
-218.77%-3.52B
-103.74%-2.78B
Net common stock issuance
----
----
----
--0
----
----
----
----
---2B
--0
Cash dividends paid
-2.85%-2.38B
-2.81%-2.38B
-3.00%-2.37B
-2.94%-9.25B
-3.12%-2.32B
-3.07%-2.31B
-3.16%-2.32B
-2.40%-2.3B
-2.91%-8.98B
-2.56%-2.25B
Net other financing activities
83.78%-6M
55.32%-63M
11.47%-386M
-88.66%-632M
-357.14%-18M
-840.00%-37M
-192.16%-141M
12.80%-436M
-2,193.75%-335M
-96.52%7M
Cash from discontinued financing activities
Financing cash flow
-22.68%-4.64B
-109.05%-2.46B
-77.95%-4.93B
275.72%26.07B
208.51%5.44B
34.40%-3.78B
978.33%27.17B
57.87%-2.77B
-51.12%-14.83B
-49.66%-5.02B
Net cash flow
Beginning cash position
-58.38%1.12B
-64.90%780M
523.29%2.92B
-76.40%468M
141.63%3.23B
47.92%2.7B
-11.58%2.22B
-76.40%468M
8.66%1.98B
-34.22%1.34B
Current changes in cash
-96.47%20M
-24.95%361M
-220.10%-2.11B
284.37%2.49B
62.68%-315M
236.96%567M
177.21%481M
230.70%1.76B
-722.12%-1.35B
-3,416.67%-844M
Effect of exchange rate changes
128.13%9M
-260.00%-18M
-1,300.00%-28M
75.76%-40M
96.15%-1M
55.56%-32M
92.42%-5M
-100.00%-2M
-179.66%-165M
3.70%-26M
End cash Position
-64.37%1.15B
-58.38%1.12B
-64.90%780M
523.29%2.92B
523.29%2.92B
141.63%3.23B
47.92%2.7B
-11.58%2.22B
-76.40%468M
-76.40%468M
Free cash flow
129.14%6.06B
-13.95%-2.42B
428.77%386M
-81.59%4.79B
-44.65%4.2B
-48.45%2.65B
-128.60%-2.12B
-98.76%73M
-12.85%26.03B
54.34%7.58B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 29, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Oct 1, 2023(Q2)Jul 2, 2023(Q1)Apr 2, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 94.13%6.71B-47.31%-1.78B-9.91%1.09B-70.27%8.7B-38.93%5.24B-42.07%3.46B-114.79%-1.21B-81.49%1.21B-11.10%29.27B44.70%8.58B
Net income from continuing operations 287.65%4.48B-98.68%31M-43.69%3.13B-93.08%2.17B-166.69%-3.34B-127.63%-2.39B-76.31%2.34B-29.50%5.56B39.81%31.4B39.77%5B
Depreciation and amortization 12.50%1.76B10.04%1.73B16.75%1.74B24.21%6.29B9.94%1.67B31.87%1.56B33.87%1.57B25.27%1.49B-2.45%5.06B13.78%1.52B
Deferred tax -326.55%-482M10.31%-783M26.25%-441M8.55%-3.44B-409.04%-1.86B-282.26%-113M23.42%-873M74.24%-598M12.32%-3.76B46.56%-365M
Other non cash items -46.69%-842M151.02%274M-253.00%-353M-970.00%-4.28B-127.50%-3.07B-228.00%-574M-175.10%-537M-124.45%-100M91.48%-400M-47.27%-1.35B
Change In working capital 173.31%879M9.73%-3.54B39.42%-3.34B61.48%-2.17B246.03%8.45B73.85%-1.2B-41.58%-3.92B-654.38%-5.51B-144.04%-5.64B26.07%2.44B
-Change in receivables ------------32.95%347M----------------106.85%261M----
-Change in inventory -------------97.80%-1.17B----------------47.47%-591M----
-Change in payables and accrued expense -------------125.19%-300M-----------------4.11%1.19B----
-Change in other current assets ------------85.29%-663M-----------------326.30%-4.51B----
-Change in other current liabilities ------------141.06%595M-----------------107.74%-1.45B----
-Change in other working capital -------------80.18%-982M----------------53.26%-545M----
Cash from discontinued investing activities 00
Operating cash flow 94.27%6.71B-47.43%-1.78B-10.07%1.09B-70.27%8.7B-38.94%5.24B-42.15%3.46B-114.79%-1.21B-81.47%1.21B-10.17%29.27B45.11%8.58B
Investing cash flow
Cash flow from continuing investing activities -331.24%-2.06B118.05%4.6B-47.80%1.73B-104.50%-32.28B-149.31%-11B242.40%890M-125.26%-25.49B484.83%3.32B29.96%-15.78B-70.84%-4.41B
Net PPE purchase and sale 19.63%-651M30.31%-637M38.19%-704M-20.74%-3.91B-4.30%-1.04B3.69%-810M-21.70%-914M-77.14%-1.14B-19.37%-3.24B0.10%-1B
Net business purchase and sale --0--0--3.49B-88.85%-43.43B-158.79%-43.41B--0---25M--0---23B---16.77B
Net investment purchase and sale -204.59%-1.41B121.88%5.26B-123.61%-1.06B128.06%15.24B150.40%33.44B137.14%1.35B-129.11%-24.02B-39.94%4.47B134.24%6.68B911.79%13.35B
Net other investing changes -98.28%6M96.37%-19M105.26%1M6.25%-180M66.67%15M413.51%348M-580.52%-524M-46.15%-19M37.25%-192M-86.15%9M
Cash from discontinued investing activities
Investing cash flow -331.64%-2.06B118.05%4.6B-47.75%1.73B-104.51%-32.28B-149.34%-11B241.63%888M-125.27%-25.49B484.66%3.32B30.00%-15.78B-70.53%-4.41B
Financing cash flow
Cash flow from continuing financing activities -22.68%-4.64B-109.05%-2.46B-77.95%-4.93B275.72%26.07B208.51%5.44B34.40%-3.78B977.95%27.18B57.88%-2.77B-51.12%-14.83B-49.66%-5.02B
Net issuance payments of debt -57.56%-2.25B-100.05%-16M-6,690.63%-2.17B1,122.33%35.95B379.98%7.78B59.44%-1.43B542.59%29.63B98.25%-32M-218.77%-3.52B-103.74%-2.78B
Net common stock issuance --------------0-------------------2B--0
Cash dividends paid -2.85%-2.38B-2.81%-2.38B-3.00%-2.37B-2.94%-9.25B-3.12%-2.32B-3.07%-2.31B-3.16%-2.32B-2.40%-2.3B-2.91%-8.98B-2.56%-2.25B
Net other financing activities 83.78%-6M55.32%-63M11.47%-386M-88.66%-632M-357.14%-18M-840.00%-37M-192.16%-141M12.80%-436M-2,193.75%-335M-96.52%7M
Cash from discontinued financing activities
Financing cash flow -22.68%-4.64B-109.05%-2.46B-77.95%-4.93B275.72%26.07B208.51%5.44B34.40%-3.78B978.33%27.17B57.87%-2.77B-51.12%-14.83B-49.66%-5.02B
Net cash flow
Beginning cash position -58.38%1.12B-64.90%780M523.29%2.92B-76.40%468M141.63%3.23B47.92%2.7B-11.58%2.22B-76.40%468M8.66%1.98B-34.22%1.34B
Current changes in cash -96.47%20M-24.95%361M-220.10%-2.11B284.37%2.49B62.68%-315M236.96%567M177.21%481M230.70%1.76B-722.12%-1.35B-3,416.67%-844M
Effect of exchange rate changes 128.13%9M-260.00%-18M-1,300.00%-28M75.76%-40M96.15%-1M55.56%-32M92.42%-5M-100.00%-2M-179.66%-165M3.70%-26M
End cash Position -64.37%1.15B-58.38%1.12B-64.90%780M523.29%2.92B523.29%2.92B141.63%3.23B47.92%2.7B-11.58%2.22B-76.40%468M-76.40%468M
Free cash flow 129.14%6.06B-13.95%-2.42B428.77%386M-81.59%4.79B-44.65%4.2B-48.45%2.65B-128.60%-2.12B-98.76%73M-12.85%26.03B54.34%7.58B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data